Metoprolol succ ER 25 MG tab 1000S
Ended Awarded
- Contract number
- SPE2DR26F0VT0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,053
Award facts
- Contract value 100% obligated
- $1,052.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended-Release 25 mg, with a ceiling value of $1,052.74. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by October 27, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor specializing in supplying medications and medical supplies to military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Metoprolol, a beta-blocker commonly used to treat hypertension and cardiac conditions, represents the type of essential pharmaceutical commodity that AmerisourceBergen regularly provides to support Defense Health Agency and other federal healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F0VT0?
SPE2DR26F0VT0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26F0VT0 worth?
The government has obligated $1,053 on SPE2DR26F0VT0.
Is contract SPE2DR26F0VT0 an order under another contract?
Yes. SPE2DR26F0VT0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0VT0 competed?
The extent of competition for SPE2DR26F0VT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award